June 26, 2022

Medical Trend

Medical News and Medical Resources

CDC: Monkeypox is not COVID and is not easily airborne.

CDC: Monkeypox is not COVID and is not easily airborne.



 

CDC: Monkeypox is not COVID and is not easily airborne.

The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that monkeypox virus is not easily spread through the air, but mostly by close contact with infected people.

 

 

Since the beginning of May, there have been many rare cases of monkeypox in North America and Europe, which has caused concern to the outside world.

The US Centers for Disease Control and Prevention (CDC) hopes to quell doubts about the transmission route of monkeypox virus, emphasizing that monkeypox virus will not easily spread through the air, Rather, it requires close contact with an infected person.

 

CDC officials said this week that monkeypox occurs primarily through constant physical contact, such as skin contact with an infected person who develops a rash, CNBC reported.

The virus can also be spread through contact with objects that contain the virus, such as shared bedding and clothing.

However, they say monkeypox virus is also spread through respiratory droplets, but not as easily as COVID-19 (coronavirus disease 2019).

 

CDC official Dr. Jennifer McQuiston told the media on a conference call on the 23rd: “This is not COVID, and respiratory transmission is not the main concern. In the setting and population of the current outbreak, it is through contact and close contact.”

 

“It’s not the kind of situation where you’re at the grocery store and you’re walking by someone and you’re at risk of infection.”

 

“The lesions that are unique to monkeypox are where the virus spreads, and people are most contagious when they appear on the skin,” said John Brooks, an epidemiologist with the AIDS Prevention Division at the CDC. “

 

The recent outbreak of monkeypox in multiple countries is also different from the COVID-19 outbreak, because there is a federally approved vaccine that can effectively prevent monkeypox.

The U.S. currently has a stockpile of 100 million doses of the old-generation smallpox vaccine, but because of the potential for significant side effects, any decision to distribute it widely is still subject to rigorous discussion.

 

Jynneos, another vaccine against smallpox and monkeypox, did not have a similarly significant risk of side effects. People over 18 at high risk of contracting smallpox and monkeypox must receive two doses.

McQuiston said the U.S. currently has only 1,000 doses of the vaccine in stock, but Jynneos vaccine maker Bavarian Nordic A/S will ramp up production in the coming weeks.

 

In addition to the successive reports of monkeypox cases in many European and North American countries such as the United Kingdom, France and the United States, national health authorities in the Czech Republic, Austria and Slovenia also reported the first cases of monkeypox in the country on the 24th.

 

Pavel Dlouhy, president of the Czech Society for Infectious Diseases, said a man was reported to be infected with monkeypox at the Military University Hospital in Prague.

 

“It’s a matter of time. We’ve been anticipating this for days,” Delauch told AFP.

 

The Czech National Institute of Public Health said in a statement that the Czech patient developed symptoms after returning from a music festival in Antwerp in Belgium in early May.

 

In Austria, Vienna health authorities said that a man hospitalized in Vienna on the 22nd developed symptoms of monkeypox such as fever and had been diagnosed with infection.

 

A man who developed symptoms after returning from Spain’s Canary Islands has also been diagnosed with monkeypox, Slovenian authorities said.

 

Health authorities have previously said the risk of a widespread monkeypox outbreak is not high.

 

 

 

 

 

CDC: Monkeypox is not COVID and is not easily airborne.

(source:internet, reference only)


Disclaimer of medicaltrend.org